Australia markets closed

Eagle Pharmaceuticals, Inc. (EGRX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
5.99+0.02 (+0.34%)
At close: 04:00PM EST
5.99 0.00 (0.00%)
After hours: 08:00PM EST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
298,231
316,610
171,546
187,802
Cost of revenue
87,379
94,936
42,180
45,465
Gross profit
210,852
221,674
129,366
142,337
Operating expenses
Research development
30,658
34,088
51,275
30,785
Selling general and administrative
102,801
106,626
75,322
78,598
Total operating expenses
133,459
140,714
126,597
109,383
Operating income or loss
77,393
80,960
2,769
32,954
Interest expense
2,506
4,045
1,635
2,577
Total other income/expenses net
-25,699
-15,753
-6,242
-8,262
Income before tax
49,353
61,433
-4,548
22,677
Income tax expense
28,072
25,791
4,079
10,688
Income from continuing operations
21,281
35,642
-8,627
11,989
Net income
21,281
35,642
-8,627
11,989
Net income available to common shareholders
21,281
35,642
-8,627
11,989
Basic EPS
0.88
2.76
-0.66
0.89
Diluted EPS
0.85
2.73
-0.66
0.87
Basic average shares
13,085
12,934
13,051
13,482
Diluted average shares
13,165
13,065
13,051
13,771